NCT06443138

Brief Summary

Surgical management is one of the most frequently used interventions in the treatment of many cancers, but it can be associated with a high risk of postoperative complications. The maintenance and optimization of functional abilities before, during and after treatment are major for elderly cancer patients, as it is now well established that there is a link between the level of functional capacity and the occurrence of these complications. The scientific literature shows that the benefits of pre- and post-operative training programs, but these benefits only apply to a fraction of the patients adhering to the programs. The modalities of intervention (training load, follow-up, etc.) as well as patient involvement in these programs are major issues that need to be addressed to optimize their benefits. Individualizing pre-habilitation, on the basis of the management of the training load, and therefore objective fatigue, would enable better patient adherence to the program, and optimize its benefits. In this context, the PRIMECHO project aims to individualize pre-habilitation in order to improve functional of patients in the pre-habilitation or accelerated recovery after surgery phase. The aim is for the patient to be in optimum physical condition at the time of the intervention or treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
17mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Nov 2024Nov 2027

First Submitted

Initial submission to the registry

May 23, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 5, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

November 6, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 10, 2027

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

3 years

First QC Date

May 23, 2024

Last Update Submit

March 17, 2026

Conditions

Keywords

ederlycancer

Outcome Measures

Primary Outcomes (4)

  • Maximal walking distance to 6 -MWT

    Metres walked during 6 minutes

    at inclusion

  • Maximal walking distance to 6 -MWT

    Metres walked during the test

    at 4 weeks

  • Maximal walking distance to 6 -MWT

    Metres walked during the test

    at 8 weeks

  • Maximal walking distance to 6 -MWT

    Metres walked during the test

    at 16 weeks

Secondary Outcomes (3)

  • EORTC-QLQC30

    at inclusion, 4 weeks, 8 weeks, 16 weeks

  • Fatigue scale (MFI-20)

    at inclusion, 4 weeks, 8 weeks, 16 weeks

  • Internationnal Physiqual activity questionaire (IPAQ-short)

    at inclusion, 4 weeks, 8 weeks, 16 weeks

Study Arms (1)

Personalized pre-habilitation program

EXPERIMENTAL
Other: Personalized pre-habilitation program

Interventions

Each patient will undergo 4 weeks of individualized pre-habilitation before surgery. Each session (1 session per day) will be carried out autonomously by the patient at home, via a dedicated application (Activiti Pro) installed on their tablet or smartphone.

Personalized pre-habilitation program

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patient aged 70 or over
  • Cancer patient with planned surgery,
  • Mini Mental State Examination score greater than or equal to 24 (performed in advance by the geriatrician),
  • Patient affiliated to or benefiting from a social security insurance
  • Signed free and informed consent.

You may not qualify if:

  • Inability to walk or perform unsupervised exercises.
  • Vulnerable people

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nice

Nice, France

RECRUITING

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Rabia Boulahssass, MD

    Centre Hospitalier Universitaire de Nice

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Rabia Boulahssass, MD

CONTACT

Frédéric Chorin

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: Implementation of a personalized pre-habilitation program at home before surgery
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2024

First Posted

June 5, 2024

Study Start

November 6, 2024

Primary Completion (Estimated)

November 10, 2027

Study Completion (Estimated)

November 10, 2027

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations